Our 10 yr old son has a point mutation in Exon 3 that should result in a severe DMD phenotype. However he presents as a milder BMD phenotype, possibly due to a re-initiation of translation resulting in a low level of dystrophin. Does anyone else have a similar situation?
My boy have a deletion of exon 3-7. They are 16 and 13 and still walking well.
We had biopsies taken for a study of our deletion sent to Dr.Steve Wilton in Australia 2 years ago. We have not had any feedback on that yet, but we see Dr.Wong in Aug so maybe we will get some info then. They are also on Deflazacort and Losartan so that might be having a synergistic affect with the small amount of dystrophin they have.